EUVIMEDEUVIMED entdecken
Crossref

Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies

Eero Poukka iD, Caitriona Murphy, Loretta Mak, Samuel M S Cheng, Malik Peiris, Tim K Tsang, Sheena G Sullivan, Benjamin J Cowling

International Journal of Epidemiology · 2025

DOI: 10.1093/ije/dyaf089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Epidemiology, 2025. Verfasst von Eero Poukka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Vaccine Efficacy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Health and Medical Research Fund, Health Bureau, Government of the Hong Kong Special Administrative Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In test-negative design (TND) studies that use rapid tests to estimate influenza vaccine effectiveness (VE), a common concern is case–control misclassification due to imperfect diagnostic accuracy. An imperfect test can also fail to exclude from the control group people infected with other influenza types or other vaccine-preventable respiratory viruses. We investigated these biases while evaluating VE for the 2023/24 seasonal influenza vaccination.

Methods

A TND study was conducted among outpatients aged ≥6 months of age who visited an outpatient clinic in Hong Kong between 15 December 2023 and 13 August 2024. VE was estimated for polymerase chain reaction (PCR)- and rapid-test-confirmed influenza A and B with exclusions of other types of influenza and SARS-CoV-2 based on either PCR or rapid test. Alternatively, for the exclusion of SARS-CoV-2, we adjusted the analysis with COVID-19 vaccination. VE was estimated by using logistic regression adjusted for confounders.

Results

In a study population of 1691 participants, VE against influenza A by PCR was 49% [95% confidence interval (CI) 26%–65%] after the exclusion of PCR-confirmed influenza B and SARS-CoV-2 controls. The corresponding VE against influenza B was 65% (95% CI 35%–81%). VE estimated by adjusting for COVID-19 vaccination status yielded similar estimates to these. When case–control status and exclusions from test-negative controls were determined by using the rapid test, VE was reduced by 5%age–15%age points.

Conclusion

In TND studies using rapid tests, reduced sensitivity affects both case–control classification and control group exclusions, potentially causing bias. New methods for these biases could help to adapt participatory cohorts for the monitoring of VE for influenza, COVID-19, and respiratory syncytial virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanVaccine EfficacyHumansMaleFemaleHong KongMiddle AgedAdultAgedAdolescentInfantChild, PreschoolYoung AdultCOVID-19ChildSARS-CoV-2BiasInfluenza B virusCase-Control StudiesSelection Bias

Stichwörter der Autor:innen

PCR testbiasinfluenzarapid testtest-negative designvaccine effectiveness

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Department of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administ…
  • Centre for Immunology and Infection, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China.
  • Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China.
  • School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.

ORCID-Profile: Eero Poukka

Förderung

  • Health and Medical Research Fund, Health Bureau
  • Government of the Hong Kong Special Administrative Region

Zitieren

APA

Poukka, E., Murphy, C., Mak, L., Cheng, S. M. S., Peiris, M., Tsang, T. K., Sullivan, S. G., & Cowling, B. J. (2025). Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyaf089

Vancouver

Poukka E, Murphy C, Mak L, Cheng SMS, Peiris M, Tsang TK, et al. Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies. International Journal of Epidemiology. 2025. doi:10.1093/ije/dyaf089

BibTeX
@article{Poukka2025,
  author = {Poukka, Eero and Murphy, Caitriona and Mak, Loretta and Cheng, Samuel M S and Peiris, Malik and Tsang, Tim K and Sullivan, Sheena G and Cowling, Benjamin J},
  title = {Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies},
  journal = {International Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/ije/dyaf089}
}
Kostenlos starten →